Drug Shortage Report for RELPAX
| Report ID | 250228 |
| Drug Identification Number | 02256304 |
| Brand name | RELPAX |
| Common or Proper name | ELETRIPTAN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ELETRIPTAN |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 6BL |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2025-02-14 |
| Actual start date | 2025-02-14 |
| Estimated end date | Unknown |
| Actual end date | 2025-02-27 |
| Shortage status | Resolved |
| Updated date | 2025-03-03 |
| Company comments | Quality Delay |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2025-03-03 | French | Compare |
| v6 | 2025-03-03 | English | Compare |
| v5 | 2025-02-18 | French | Compare |
| v4 | 2025-02-18 | English | Compare |
| v3 | 2025-02-15 | English | Compare |
| v2 | 2025-02-12 | French | Compare |
| v1 | 2025-02-12 | English | Compare |
Showing 1 to 7 of 7